CalAmp Corp. is a United States-based company, which provides device-enabled software and cloud platform. The Company's solutions include asset tracking, asset management, fleet telematics, data analytics, mobile asset intelligence (MAI) and remote asset monitoring (RAM). Its product portfolio consists of products, such as asset trackers, machine-to-machine (M2M) communication solutions, vehicle telematics solutions and other solutions.

Employees

644

Sector

Wireless Telecommunications Services

More about the company

Delayed OTC Markets Other stock markets 01:11:15 01/08/2024 am IST			5-day change	1st Jan Change
0.0700 ^USD	-30.00%		-.--%	-

10/06	Chardan Initiates Camp4 Therapeutics at Buy With $6.50 Price Target	MT
30/04	RAC Connected And CalAmp Announce CrashBoxx Integration For Real-Time Crash Intelligence	CI

Market Cap	48.37L 41.78L 38.5L 36.04L 67.53L 46Cr 68.58L 4.55Cr 1.77Cr 22Cr 1.82Cr 1.78Cr 77Cr	P/E Ratio 2022	-8.89x	P/E Ratio 2023	-4.74x
Enterprise Value	21Cr 18Cr 17Cr 16Cr 29Cr 1.98TCr 30Cr 195.69Cr 76Cr 963.36Cr 78Cr 76Cr 3.34TCr	EV / Sales 2022	1.3x	EV / Sales 2023	1.22x
Free-Float	100%	Yield 2022 *	-	Yield 2023	-

10/06	Chardan Initiates Camp4 Therapeutics at Buy With $6.50 Price Target	MT
30/04	RAC Connected And CalAmp Announce CrashBoxx Integration For Real-Time Crash Intelligence	CI
26/03	CalAmp Adds Google Pub/Sub Integration to Telematics Cloud, Accelerating Data Delivery for Google Cloud Customers	CI
05/03	CalAmp Corp. Announces CEO Changes	CI
06/02	CalAmp Launches Next-Generation Here Comes the Bus Parent App with Enhanced Safety and Security	CI
27/01	The RAC and CalAmp Partner to Expand RAC Connected Telematics with Advanced Fleet Management and AI Video for UK Fleets	CI
19/12	Top Midday Decliners	MT
18/12	CAMP4 Therapeutics, GSK Collaborate to Develop RNA-Based Therapeutics for Neurodegenerative and Kidney Diseases	MT
18/12	Camp4 Therapeutics Prices $30 Million Offering; Shares Fall Pre-Bell	MT
02/25/02	Cantor Fitzgerald Initiates CAMP4 Therapeutics at Overweight With $7 Price Target	MT
16/25/16	JPMorgan Downgrades Camp4 Therapeutics to Neutral From Overweight	MT
12/25/12	Camp4 Therapeutics Insider Bought Shares Worth $1,999,999, According to a Recent SEC Filing	MT
10/25/10	Camp4 Therapeutics Seeks to Raise Up to $100 Million in Private Placement; Shares Up Pre-Bell	MT

10/06	Chardan Initiates Camp4 Therapeutics at Buy With $6.50 Price Target	MT
02/25/02	Cantor Fitzgerald Initiates CAMP4 Therapeutics at Overweight With $7 Price Target	MT
16/25/16	JPMorgan Downgrades Camp4 Therapeutics to Neutral From Overweight	MT
27/25/27	Wedbush Initiates CAMP4 Therapeutics at Outperform With $8 Price Target	MT
05/24/05	William Blair Initiates Camp4 Therapeutics at Outperform	MT

CalAmp Share Price

Stocks

CAMP

US1281262089

Wireless Telecommunications Services

Valuation: CalAmp

Latest news : CalAmp

Analysts' recommendations: CalAmp

Press Releases: CalAmp

News in other languages: CalAmp

Quotes and Performance

Course Extremes

Managers and Directors: CalAmp

Latest insider transactions

Other Wireless Telecommunications Services

Financials

Company Profile

01/24/01	CalAmp : OF THE BANKRUPTCY CODE AND (II) GRANTING RELATED RELIEF Form 8 K	PU
18/24/18	CalAmp : OF THE BANKRUPTCY CODE AND (II) GRANTING RELATED RELIEF Form 8 K	PU
03/24/03	CalAmp Reaches Comprehensive Agreement to Significantly Reduce Debt, Go Private, and Strengthen Financial Flexibility to Support Innovation Through a Consensual Financial Restructuring	AQ
03/24/03	CALAMP : REACHES COMPREHENSIVE AGREEMENT TO SIGNIFICANTLY REDUCE DEBT, GO PRIVATE, AND STRENGTHEN FINANCIAL FLEXIBILITY TO SUPPORT INNOVATION THROUGH A CONSENSUAL FINANCIAL RESTRUCTURING - Form 8-K	PU
02/24/02	CalAmp Enhances School Bus Solutions Suite with Dispatch Monitor	AQ

06/23/06	MORNING BRIEFING - USA/Asien
18/23/18	LoJack : rafforza monitoraggio su flotte aziendali
05/22/05	Alis : con LoJack per supportare transizione digitale logistica
22/16/22	American Airlines : Les valeurs à suivre sur les marchés américains
22/16/22	USA-Les valeurs à suivre à Wall Street

Manager	Title	Age	Since
Iperti Maurizio CEO	Chief Executive Officer	61	05/03/2026
Jikun Kim DFI	Director of Finance/CFO	61	09/01/2023
Xiao Lian Zhang DFI	Director of Finance/CFO	-	01/10/2022

Date	Insider	Type	Main position	Quantity	% Market Cap.
05/24/05	Jason Cohenour	Sell	Chief Executive Officer	8,640	0.5230%
05/24/05	Jikun Kim	Tax	Chief Financial Officer	487	0.0295%
05/24/05	Jason Cohenour	Fiscal year	Chief Executive Officer	17,970	1.0878%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CALAMP	-30.00%	-.--%	-.--%	-99.85%	1L
SPACEX (SPACE EXPLORATION TECHNOLOGIES)	+23.26%	0.00%	-	-	1,76700Cr
SOFTBANK GROUP CORP.	+1.54%	-12.27%	+220.40%	+338.71%	23TCr
T-MOBILE US, INC.	+1.77%	+6.82%	-18.12%	+43.96%	20TCr
AT&T INC.	+2.52%	+3.56%	-16.80%	+47.84%	16TCr
KDDI CORPORATION	+0.42%	+4.75%	+14.19%	+23.84%	6.54TCr
VODAFONE GROUP PLC	+1.80%	+4.70%	+59.96%	+54.58%	3.49TCr
ADVANCED INFO SERVICE	+1.95%	+1.67%	+25.34%	+67.12%	3.24TCr
CHINA UNICOM (HONG KONG) LIMITED	-2.17%	-3.49%	-24.21%	+20.60%	2.87TCr
TELENOR ASA	+1.27%	+0.80%	-0.98%	+38.20%	2.15TCr
Average	+0.19%	-0.28%	+28.86%	+59.44%	25.37TCr
Weighted average by Cap.	+16.72%	-0.81%	+60.61%	+130.10%

	2022	2023
Net sales	30Cr 26Cr 24Cr 22Cr 41Cr 2.81TCr 42Cr 278.02Cr 108.4Cr 1.37TCr 111.03Cr 108.66Cr 4.74TCr	29Cr 25Cr 23Cr 22Cr 41Cr 2.8TCr 42Cr 277.19Cr 108.07Cr 1.36TCr 110.69Cr 108.34Cr 4.72TCr
Net income	-2.8Cr -2.42Cr -2.23Cr -2.09Cr -3.91Cr -266.06Cr -3.97Cr -26Cr -10Cr -129.5Cr -11Cr -10Cr -448.39Cr	-3.25Cr -2.81Cr -2.59Cr -2.42Cr -4.54Cr -308.82Cr -4.61Cr -31Cr -12Cr -150.31Cr -12Cr -12Cr -520.46Cr
Net Debt	13Cr 11Cr 10Cr 9.8Cr 18Cr 1.25TCr 19Cr 123.61Cr 48Cr 608.54Cr 49Cr 48Cr 2.11TCr	20Cr 18Cr 16Cr 15Cr 28Cr 1.93TCr 29Cr 191.14Cr 75Cr 940.98Cr 76Cr 75Cr 3.26TCr

3 years	0.02	48.76
5 years	0.02	332.12
10 years	0.02	585.35